Literature DB >> 20833245

Virological and clinico-pathological features of orf virus infection in experimentally infected rabbits and mice.

J F Cargnelutti1, E K Masuda, M Martins, D G Diel, D L Rock, R Weiblen, E F Flores.   

Abstract

Many aspects of the biology of orf virus (ORFV) infection remain poorly understood and attempts to establish animal models have yielded conflicting and non-reproducible results. We herein describe the characterization of ORFV infection and disease in rabbits and mice. A protocol of intradermal inoculation was employed to inoculate 10(8.5)TCID₅₀/mL of ORFV strain IA-82 in the skin of ears, of the back and labial commissures. All inoculated rabbits presented a clinical course characterized by erythema, macules, papules/vesicles or pustules that eventually dried originating scabs. Local signs started around days 3 and 4 post-inoculation (pi) and lasted 3-10 days. Virus was recovered from lesions between days 2 and 14pi. Histological examination of lesions revealed focal proliferative dermatitis with ballooning degeneration and eosinophilic intracytoplasmic inclusion bodies in keratinocytes, histological hallmarks of contagious ecthyma in sheep. A similar, albeit milder clinical course occurred in 5/10 inoculated mice; virus was recovered from lesions from three animals. Inoculated lambs - used as controls - developed severe lesions of contagious ecthyma. VN tests performed at day 28pi failed to detect neutralizing antibodies in all inoculated animals. In contrast, convalescent rabbit sera were positive by ELISA at dilutions from 100 to 400. These results show that rabbits are susceptible to ORFV infection and thus may be used to study selected aspects of ORFV biology. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20833245     DOI: 10.1016/j.micpath.2010.08.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Functional analysis of the short isoform of orf virus protein OV20.0.

Authors:  Yeu-Yang Tseng; Fong-Yuan Lin; Sun-Fang Cheng; David Tscharke; Songkhla Chulakasian; Chia-Chi Chou; Ya-Fen Liu; Wei-Shan Chang; Min-Liang Wong; Wei-Li Hsu
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

2.  Orf virus DNA vaccines expressing ORFV 011 and ORFV 059 chimeric protein enhances immunogenicity.

Authors:  Kui Zhao; Wenqi He; Wei Gao; Huijun Lu; Tiesuo Han; Jing Li; Ximu Zhang; Bingbing Zhang; Gaili Wang; Gaoli Su; Zhihui Zhao; Deguang Song; Feng Gao
Journal:  Virol J       Date:  2011-12-29       Impact factor: 4.099

3.  Dermatopathology of Orf Virus (Malaysian Isolates) in Mice Experimentally Inoculated at Different Sites with and without Dexamethasone Administration.

Authors:  Jamilu Abubakar Bala; Krishnan Nair Balakrishnan; Ashwaq Ahmed Abdullah; Tay Kimmy; Yusuf Abba; Ramlan Bin Mohamed; Faez Firdaus Abdullah Jesse; Abd Wahid Haron; Mustapha Mohamed Noordin; Asinamai Athliamai Bitrus; Idris Umar Hambali; Mohd Azmi Mohd Lila
Journal:  J Pathog       Date:  2018-08-01

4.  Orf virus (ORFV) infection in a three-dimensional human skin model: Characteristic cellular alterations and interference with keratinocyte differentiation.

Authors:  Mahmod Muhsen; Martina Protschka; Laura E Schneider; Uwe Müller; Gabriele Köhler; Thomas M Magin; Mathias Büttner; Gottfried Alber; Sabine Siegemund
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

5.  Recombinant B2L and Kisspeptin-54 DNA Vaccine Induces Immunity Against Orf Virus and Inhibits Spermatogenesis In Rats.

Authors:  Teketay Wassie; Zeng Fanmei; Xunping Jiang; Guiqiong Liu; Shishay Girmay; Zhang Min; Liu Chenhui; Dong Dong Bo; Sohail Ahmed
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

6.  Molecular characterization of Orf virus isolates from Kodai hills, Tamil Nadu, India.

Authors:  G Nagarajan; R Pourouchottamane; G B Manjunatha Reddy; R Yogisharadhya; K Sumana; S Rajapandi; G Murali; S M K Thirumaran; P K Mallick; A S Rajendiran
Journal:  Vet World       Date:  2019-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.